Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | CD274 | Q9NZQ7 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | MAOB | P27338 | 1/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
| ▸ | MMP12 | P39900 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL280406 | 0.92 | MEN1 (0.76) | MEN1KMT2AL3MBTL1ALDH1A1GLA | |
| SCHEMBL8592462 | 0.89 | CD274 (0.58) | MEN1KMT2AL3MBTL1CD274ALDH1A1 | |
| SCHEMBL277129 | 0.87 | ALDH1A1 (0.52) | MEN1KMT2AL3MBTL1ALDH1A1CA2 | |
| SCHEMBL277405 | 0.87 | KMT2A (0.61) | MEN1KMT2AL3MBTL1CD274ALDH1A1 | |
| SCHEMBL279580 | 0.85 | KMT2A (0.62) | MEN1KMT2AL3MBTL1CD274ALDH1A1 | |
| SCHEMBL11919030 | 0.84 | KMT2A (0.61) | MEN1KMT2AL3MBTL1CD274ALDH1A1 | |
| SCHEMBL13354501 | 0.83 | KMT2A (0.60) | MEN1KMT2AL3MBTL1CD274ALDH1A1 | |
| SCHEMBL11916012 | 0.82 | KMT2A (0.59) | MEN1KMT2AL3MBTL1CD274ALDH1A1 | |
| SCHEMBL22515316 | 0.82 | KMT2A (0.59) | MEN1KMT2AL3MBTL1CD274ALDH1A1 | |
| SCHEMBL15259159 | 0.81 | CD274 (0.57) | MEN1KMT2AL3MBTL1CD274ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8134013-B2 | Amide compound and thrombopoietin receptor activator | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-03-13 | — | — | US | disclosed |
| US-20090131659-A1 | AMIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131659-A1 | AMIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR | TEK, PTAFR, MPL | MEN1 605/4885KMT2A 3398/4885L3MBTL1 676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.